Penserra Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,180
| Closed | -$129K | – | 1419 |
|
|
2021
Q3 | $129K | Buy |
2,180
+40
| +2% | +$2.37K | ﹤0.01% | 712 |
|
|
2021
Q2 | $185K | Buy |
2,140
+20
| +0.9% | +$1.73K | ﹤0.01% | 656 |
|
|
2021
Q1 | $174K | Buy |
2,120
+110
| +5% | +$9.03K | ﹤0.01% | 606 |
|
|
2020
Q4 | $182K | Buy |
2,010
+1,270
| +172% | +$115K | ﹤0.01% | 546 |
|
|
2020
Q3 | $29K | Buy |
+740
| New | +$29K | ﹤0.01% | 696 |
|